Bureaucrats vs. Physicians: Have Doctors Been Stripped of Their Power to Determine the Proper Use of Human Growth Hormone in Treating Adult Disease?

Keywords

Somatotropin, Legislative intent, Off label prescribing, Food, Drug and Cosmetic Act, Growth Hormone deficiency (GHd), Human growth hormone (hGH), Controlled Substances Act, Administrative deference, Physicians, United States

Share

Authors

Ryan Cronin (Washington University School of Law)

Download

Issue

Publication details

Dates

Licence

All rights reserved

File Checksums (MD5)

  • pdf: 72499e07eec39a9f638c95dfadc263d5